|
On the 5th, Japan's "Sankei Shimbun" published a report entitled "Defense Province's New System to Accelerate Civil Technology for Defense Equipment" that Japan intends to accelerate the "militaryization" of civil technology. The full text is as follows: The reporter was informed on the 4th that in order to promote cutting -edge technology by private enterprises for defense equipment, the Ministry of Defense of Japan is planning to launch a new "certification system." Several defensive people confirmed the news. The purpose of this move is to integrate the technological innovation capabilities of the economy under the background of the rapid development of civil technology, including startups that have continuously introduced new formats to achieve these technologies as soon as possible for defense equipment. The new system is planned to start trial operation before the revision of the National Security Protection Strategy was completed at the end of this year. The new system stipulates that the Ministry of Defense will accept proposals for systems and defense equipment specially submitted to the use of cutting -edge technologies, and specially certify the proposals with high urgency and importance. The newly established province's cross -departments promotion team leads the formulation of policies. After research and development and trial production, it is used as fast as possible to manufacture defense equipment as much as possible. The main technologies conceived include: "unmanned technology" represented by drones; "new battlefields such as air -proof zone" that can launch long -range missiles from the enemy's range; Combat technology; next -generation communication technology including 5G communication system; artificial intelligence technology. |
|
The "new therapy" aimed at treating Alzheimer's disease such as Alzheimer is accelerating the pace of development. Regarding head ultrasound therapy, the final clinical trials will be launched in Japan in 2022. Stem cell nerve regeneration technology also shows the possibility of obtaining treatment. Both therapeutic mechanisms of the two therapies are different from the United States Biogen and Japanese guards in 2021 to obtain conditional approval drugs in the United States. The goal is to achieve fundamental treatment. The development of Alzheimer's ultrasonic therapy is Sound Wave Innovation, a startup from Northeast University in Japan. The method is to wear a dedicated equipment on the patient's head and expose a total of 1 hour with ultrasonic waves. 3 times a week for 1 course of treatment, repeated every 3 months. The safety of this therapy has been confirmed in clinical trials from 2018 to 2019. In 2019, clinical trials were implemented with about 20 people, including mild Alzheimer's dementia patients and mild cognitive impairment (MCI) patients. Preliminary analysis shows that patients receiving the therapy have a tendency to deteriorate significantly. The clinical trial was planned to start the final stage with more patients in 2022. If the treatment effect is displayed, it is expected to obtain pharmaceutical approval in Japan in 2026. |
